These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6374056)

  • 1. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution.
    August CS; Serota FT; Koch PA; Burkey E; Schlesinger H; Elkins WL; Evans AE; D'Angio GJ
    J Clin Oncol; 1984 Jun; 2(6):609-16. PubMed ID: 6374056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation for advanced neuroblastoma using teniposide, doxorubicin, melphalan, cisplatin, and total-body irradiation.
    McCowage GB; Vowels MR; Shaw PJ; Lockwood L; Mameghan H
    J Clin Oncol; 1995 Nov; 13(11):2789-95. PubMed ID: 7595740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group.
    Garaventa A; Rondelli R; Lanino E; Dallorso S; Dini G; Bonetti F; Arrighini A; Santoro N; Rossetti F; Miniero R; Andolina M; Amici A; Indolfi P; Lo Curto M; Favre C; Paolucci P; Pession A; De Bernardi B
    Bone Marrow Transplant; 1996 Jul; 18(1):125-30. PubMed ID: 8832005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
    Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
    Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution (BMRc). Results of a four-institution Children's Cancer Study Group pilot study.
    D'Angio GJ; August C; Elkins W; Evans AE; Seeger R; Lenarsky C; Feig S; Wells J; Ramsay N; Kim T
    Prog Clin Biol Res; 1985; 175():557-63. PubMed ID: 3887431
    [No Abstract]   [Full Text] [Related]  

  • 7. [High-dose chemoradiotherapy with bone marrow transplantation as a consolidation treatment of neuroblastoma. Results in 49 unselected patients with stage IV cancer and older than 1 year. Report of the LMCE neuroblastoma group].
    Kremens B; Philip T; Bernard JL; Zucker JM
    Klin Padiatr; 1987; 199(3):218-23. PubMed ID: 3306132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloablative combination chemotherapy without total body irradiation for neuroblastoma.
    Kushner BH; O'Reilly RJ; Mandell LR; Gulati SC; LaQuaglia M; Cheung NK
    J Clin Oncol; 1991 Feb; 9(2):274-9. PubMed ID: 1899111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teniposide, doxorubicin, melphalan, cisplatin, and total body irradiation with autologous bone marrow transplantation for advanced neuroblastoma.
    Lam-Po-Tang PR; McCowage GB; Vowels MR
    Transplant Proc; 1993 Oct; 25(5):2881-2. PubMed ID: 8212272
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractionated total body irradiation, high-dose melphalan, etoposide, and carboplatin (FTBI-MEC) for autologous stem cell transplantation in children with advanced neuroblastoma and primitive neuroectodermal tumor.
    Emminger W; Gadner H
    Pediatr Hematol Oncol; 1992; 9(2):183-5. PubMed ID: 1356004
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation.
    Tarbell NJ; Guinan EC; Chin L; Mauch P; Weinstein HJ
    Radiother Oncol; 1990; 18 Suppl 1():139-42. PubMed ID: 2247640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma.
    Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
    J Clin Oncol; 1987 Aug; 5(8):1205-11. PubMed ID: 3305792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
    Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
    Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma].
    Berthold F; Bender-Götze C; Dopfer R; Erttmann R; Haas RJ; Henze G; Körbling M; Riehm H; Rister M; Stollmann B
    Klin Padiatr; 1988; 200(3):221-5. PubMed ID: 3062259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.
    Matthay KK
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S21-4. PubMed ID: 8971402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
    Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
    J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II study.
    Pinkerton CR; Philip T; Biron P; Frapazz D; Phillipe N; Zucker JM; Bernard JL; Philip I; Kemshead J; Favrot M
    Med Pediatr Oncol; 1987; 15(5):236-40. PubMed ID: 3309605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.
    Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J
    Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of neuroblastoma: role of total body irradiation].
    Franzone P; Corvò R; Dini G; Perin GP; Scarpati D
    Radiol Med; 1986 Dec; 72(12):959-62. PubMed ID: 3541069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
    Seeger RC; Villablanca JG; Matthay KK; Harris R; Moss TJ; Feig SA; Selch M; Ramsay N; Reynolds CP
    Prog Clin Biol Res; 1991; 366():527-33. PubMed ID: 2068169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.